Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Arcadia Biosciences (RKDA) has provided an announcement.
Arcadia Biosciences announced key executive changes, with Stanley Jacot resigning as president, CEO, and director, and the company agreeing to a hefty severance package including cash, stock option vesting, and health insurance coverage. Thomas J. Schaefer steps up as the new CEO, bringing a wealth of finance experience and a solid educational background. Mark Kawakami fills Schaefer’s former CFO role, equipped with a strong analytical background and diverse financial expertise.
Find detailed analytics on RKDA stock on TipRanks’ Stock Analysis page.
